MoonLake Immunotherapeutics Quarterly Assets in USD from Q3 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: MoonLake Immunotherapeutics quarterly Assets history and growth rate from Q3 2020 to Q3 2024.
MoonLake Immunotherapeutics Assets for the quarter ending September 30, 2024 was $518M, a 3.6% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$518M	+$18M	+3.6%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$545M	+$38.3M	+7.55%	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$564M	+$497M	+745%	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$527M	+$450M	+585%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$500M	+$412M	+465%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$507M	+$408M	+415%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$66.8M	-$164M	-71.1%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$76.8M	+$67.2M	+694%	Dec 31, 2022	10-K	2024-02-29
Q3 2022	$88.6M	-$27.7M	-23.8%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$98.4M	-$17.9M	-15.4%	Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$231M	+$115M	+98.5%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$9.68M	-$107M	-91.7%	Dec 31, 2021	10-K	2023-03-20
Q3 2021	$116M	+$116M		Sep 30, 2021	10-Q/A	2021-12-14
Q2 2021	$116M			Jun 30, 2021	10-Q	2021-08-16
Q1 2021	$116M			Mar 31, 2021	10-Q	2021-05-21
Q4 2020	$117M			Dec 31, 2020	10-K	2022-02-17
Q3 2020	$164K^*			Sep 30, 2020	10-Q	2020-12-03

* An asterisk sign (*) next to the value indicates that the value is likely invalid.